Blinatumomab
About
Therapy type: Immunotherapy
Therapy strategy: CD19 inhibition
Mappings
NCI Thesaurus: Blinatumomab (coding:ncit:C62528)
RxNorm: blinatumomab (coding:rxcui:1597258, coding:omop:37396348)
SNOMED: Blinatumomab (coding:sctid:716122004, coding:omop:45892531)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) HC (1) | CD19 + | Acute Lymphoid Leukemia | Blinatumomab | |
| FDA (1) | CD19 +, not BCR::ABL1 | Acute Lymphoid Leukemia | Blinatumomab |